Rigel Pharmaceuticals Inc (RIGL) SEC Filings — 2024
27 SEC filings for Rigel Pharmaceuticals Inc (RIGL) in 2024.
Filings
- Rigel Pharmaceuticals Files 8-K Report — 8-K · Dec 9, 2024
- Rigel Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Rigel Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Rigel Pharmaceuticals Inc SC 13G Filing — SC 13G · Nov 8, 2024
- Rigel Pharmaceuticals Files 8-K on Financials — 8-K · Nov 7, 2024
- Rigel Pharmaceuticals Q3 2024: Revenue Details — 10-Q · Nov 7, 2024
- Rigel Pharmaceuticals Appoints New Chief Medical Officer — 8-K · Sep 19, 2024
- Rigel Pharmaceuticals Signs Material Definitive Agreement — 8-K · Sep 3, 2024
- Rigel Pharmaceuticals Files 8-K on Financials — 8-K · Aug 6, 2024
- Rigel Pharmaceuticals Reports Q2 2024 Financials — 10-Q · Aug 6, 2024
- Rigel Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · Jun 27, 2024
- Rigel Pharmaceuticals Files 8-K — 8-K · Jun 25, 2024
- Rigel Pharmaceuticals Elects New Directors, Approves Compensatory Plans — 8-K · May 29, 2024
- Rigel Pharmaceuticals Files 8-K on Financials — 8-K · May 7, 2024
- Rigel Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
- Rigel Pharmaceuticals Amends Credit Agreement — 8-K · Apr 12, 2024
- Rigel Pharmaceuticals Files Proxy Statement Addendum — DEFA14A · Apr 10, 2024
- Rigel Pharmaceuticals Files 8-K on Financials — 8-K · Mar 5, 2024
- Rigel Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
- Rigel Pharma Reports Material Agreement & Asset Disposition — 8-K · Feb 22, 2024
- Rigel Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Vanguard Group Amends Rigel Pharma Stake to 9.9% — SC 13G/A · Feb 13, 2024
- Morgan Stanley Discloses 6.0% Stake in Rigel Pharma (RIGL) — SC 13G · Feb 9, 2024
- Goldman Sachs Amends Rigel Pharma Stake on Dec 29, 2023 — SC 13G/A · Feb 5, 2024
- Soleus Capital Amends Rigel Pharma Stake as of Dec 31, 2023 — SC 13G/A · Feb 2, 2024
- BlackRock Amends Rigel Pharma Stake (15th Update) — SC 13G/A · Jan 25, 2024
- RIGEL PHARMACEUTICALS 8-K: Financial Condition & Other Events Update — 8-K · Jan 8, 2024